Charco Neurotech

Charco Neurotech is a medical technology company dedicated to improving the quality of life for people with Parkinson's disease through non-invasive wearable devices. The company's primary product, CUE1, utilizes localized vibrotactile stimulation and rhythmic cueing to help alleviate motor symptoms such as slowness of movement (bradykinesia) and freezing of gait. Developed based on clinical research into the effects of vibration on Parkinson's symptoms, the device attaches to the sternum and provides tactile feedback that helps users initiate and maintain fluid movement. Charco also offers a companion digital application that allows patients and clinicians to track symptom progression and customize stimulation settings. By combining hardware with data-driven insights, the company seeks to provide a holistic, non-pharmacological approach to managing the daily challenges of Parkinson's.